Deferasirox

Indication : Deferasirox is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in β-thalassemia, sickle cell disease and other rare anemias in adult and pediatric patients (aged 6 years and over).

Composition : Each Deferasirox Dispersible Tablet 250 mg contains Deferasirox 250 mg.
Each Deferasirox Dispersible Tablet 500 mg contains Deferasirox 500 mg.
Contain of excipients: Pregelatinized starch, Microcrystalline cellulose PH 101, Sodium lauryl sulfate, Povidone K-29/32, Crospovidone, Aluminium magnesium silicate, Sodium stearyl fumarate, Purified water.

Presentation :
Deferasirox Dispersible Tablet 250 mg
Box, 3 strips @ 10 dispersible tablets

Deferasirox Dispersible Tablet 500 mg
Box, 3 strips @ 10 dispersible tablets

On medical prescription only.
Store below 30⁰C, protect from light.